Extracorporeal Membrane Oxygenation after Heart Transplantation: Impact of Type of Cannulation

Abstract

Background Primary graft dysfunction (PGD) is a common cause of early death after heart transplantation (htx). The use of extracorporeal life support (ECLS) after htx has increased during the last years. It is still discussed controversially whether peripheral cannulation is favorable compared to central cannulation. We aimed to compare both cannulation techniques.

Methods Ninety patients underwent htx in our department between 2010 and 2017. Twenty-five patients were treated with ECLS due to PGD (10 central extracorporeal membrane oxygenator [cECMO] and 15 peripheral extracorporeal membrane oxygenator [pECMO] cannulation). Pre- and intraoperative parameters were comparable between both groups.

Results Thirty-day mortality was comparable between the ECLS-groups (cECMO: 30%; pECMO: 40%, p = 0.691). Survival at 1 year (n = 18) was 40 and 30.8% for cECMO and pECMO, respectively. The incidence of postoperative renal failure, stroke, limb ischemia, and infection was comparable between both groups. We also did not find significant differences in duration of mechanical ventilation, intensive care unit stay, or in-hospital stay. The incidence of bleeding complications was also similar (cECMO: 60%; pECMO: 67%). Potential differences in support duration in pECMO group (10.4 ± 9.3 vs. 5.7 ± 4.7 days, p = 0.110) did not reach statistical significance.

Conclusions In patients supported for PGD, peripheral and central cannulation strategies are safe and feasible for prolonged venoarterial ECMO support. There was no increase in bleeding after central implantation. With regard to the potential complications of a pECMO, we think that aortic cannulation with tunneling of the cannula and closure of the chest could be a good option in patients with PGD after htx.

Keywords

transplantation - heart - extracorporeal membrane oxygenation - ECMO

^* Both authors contributed equally to the study.

Publikationsverlauf

Eingereicht: 24. Juni 2019

Angenommen: 07. Oktober 2019

Artikel online veröffentlicht:
08. Februar 2020

• References

• 1 Takeda K, Li B, Garan AR. et al. Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant. J Heart Lung Transplant 2017; 36 (06) 650-656
• 2 Yusen RD, Edwards LB, Kucheryavaya AY. et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-second official adult lung and heart-lung transplantation report--2015; focus theme: early graft failure. J Heart Lung Transplant 2015; 34 (10) 1264-1277
• 3 Kobashigawa J, Zuckermann A, Macdonald P. et al; Consensus Conference participants. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J Heart Lung Transplant 2014; 33 (04) 327-340
• 4 Iyer A, Kumarasinghe G, Hicks M. et al. Primary graft failure after heart transplantation. J Transplant 2011; 2011: 175768
• 5 Sabatino M, Vitale G, Manfredini V. et al. Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: epidemiology, risk factors, and outcomes. J Heart Lung Transplant 2017; 36 (11) 1217-1225
• 6 Santise G, Panarello G, Ruperto C. et al. Extracorporeal membrane oxygenation for graft failure after heart transplantation: a multidisciplinary approach to maximize weaning rate. Int J Artif Organs 2014; 37 (09) 706-714
• 7 Allen S, Holena D, McCunn M, Kohl B, Sarani B. A review of the fundamental principles and evidence base in the use of extracorporeal membrane oxygenation (ECMO) in critically ill adult patients. J Intensive Care Med 2011; 26 (01) 13-26
• 8 D'Alessandro C, Golmard JL, Barreda E. et al. Predictive risk factors for primary graft failure requiring temporary extra-corporeal membrane oxygenation support after cardiac transplantation in adults. Eur J Cardiothorac Surg 2011; 40 (04) 962-969
• 9 Chou NK, Chi NH, Ko WJ. et al. Extracorporeal membrane oxygenation for perioperative cardiac allograft failure. ASAIO J 2006; 52 (01) 100-103
• 10 Leprince P, Aubert S, Bonnet N. et al. Peripheral extracorporeal membrane oxygenation (ECMO) in patients with posttransplant cardiac graft failure. Transplant Proc 2005; 37 (06) 2879-2880
• 11 Listijono DR, Watson A, Pye R. et al. Usefulness of extracorporeal membrane oxygenation for early cardiac allograft dysfunction. J Heart Lung Transplant 2011; 30 (07) 783-789
• 12 D'Alessandro C, Aubert S, Golmard JL. et al. Extra-corporeal membrane oxygenation temporary support for early graft failure after cardiac transplantation. Eur J Cardiothorac Surg 2010; 37 (02) 343-349
• 13 Hanna BD. Left atrial decompression: is there a standard during extracorporeal support of the failing heart?. Crit Care Med 2006; 34 (10) 2688-2689
• 14 Frazier EA, Faulkner SC, Seib PM, Harrell JE, Van Devanter SH, Fasules JW. Prolonged extracorporeal life support for bridging to transplant: technical and mechanical considerations. Perfusion 1997; 12 (02) 93-98
• 15 Jayaraman AL, Cormican D, Shah P, Ramakrishna H. Cannulation strategies in adult veno-arterial and veno-venous extracorporeal membrane oxygenation: techniques, limitations, and special considerations. Ann Card Anaesth 2017; 20 (Suppl): S11-S18
• 16 Rupprecht L, Flörchinger B, Schopka S. et al. Cardiac decompression on extracorporeal life support: a review and discussion of the literature. ASAIO J 2013; 59 (06) 547-553
• 17 Ranney DN, Benrashid E, Meza JM. et al. Vascular complications and use of a distal perfusion cannula in femorally cannulated patients on extracorporeal membrane oxygenation. ASAIO J 2018; 64 (03) 328-333
• 18 Ranney DN, Benrashid E, Meza JM. et al. Central cannulation as a viable alternative to peripheral cannulation in extracorporeal membrane oxygenation. Semin Thorac Cardiovasc Surg 2017; 29 (02) 188-195
• 19 Mikus E, Tripodi A, Calvi S, Giglio MD, Cavallucci A, Lamarra M. CentriMag venoarterial extracorporeal membrane oxygenation support as treatment for patients with refractory postcardiotomy cardiogenic shock. ASAIO J 2013; 59 (01) 18-23
• 20 Saeed D, Stosik H, Islamovic M. et al. Femoro-femoral versus atrio-aortic extracorporeal membrane oxygenation: selecting the ideal cannulation technique. Artif Organs 2014; 38 (07) 549-555
• 21 Thomas J, Kostousov V, Teruya J. Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation. Semin Thromb Hemost 2018; 44 (01) 20-29
• 22 Raffa GM, Kowalewski M, Brodie D. et al. Meta-analysis of peripheral or central extracorporeal membrane oxygenation in postcardiotomy and non-postcardiotomy shock. Ann Thorac Surg 2019; 107 (01) 311-321
• 23 Marasco SF, Vale M, Pellegrino V. et al. Extracorporeal membrane oxygenation in primary graft failure after heart transplantation. Ann Thorac Surg 2010; 90 (05) 1541-1546
• 24 Phan K, Luc JGY, Xu J. et al. Utilization and outcomes of temporary mechanical circulatory support for graft dysfunction after heart transplantation. ASAIO J 2017; 63 (06) 695-703
• 25 DeRoo SC, Takayama H, Nemeth S. et al. Extracorporeal membrane oxygenation for primary graft dysfunction after heart transplant. J Thorac Cardiovasc Surg 2019; S0022-5223(19)30512-4